Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Toftager-Larsen

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Use of tetranectin, CA-125 and CASA to predict residual tumor and survival at second- and third-look operations for ovarian cancerC K Høgdall, E V Høgdall, U Hørding, et al.
British Journal of Obstetrics and Gynaecology|February 1, 1984
Fetal cephalometry by ultrasound as a screening procedure for the prenatal detection of Down's syndromeT B Perry, R J Benzie, N Cassar, et al.
European Journal of Gynaecological Oncology|January 1, 1994
The value of CA 125 measurement before second-look laparotomy in patients with ovarian carcinomaU Hørding, K Toftager-Larsen, B Lund, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 15, 1993
Immunoreactive inhibin-production in post-menopausal women with malignant epithelial ovarian tumorsJ Blaakaer, S Micic, I D Morris, et al.
Gynecologic and Obstetric Investigation|January 1, 1990
CA 125, placental alkaline phosphatase, and tissue polypeptide antigen in the monitoring of ovarian carcinoma. A comparative study of three different tumor markersU Hørding, K Toftager-Larsen, A Dreisler, et al.
Gynecologic and Obstetric Investigation|January 1, 1992
CA-125, placental alkaline phosphatase and tissue polypeptide antigen as preoperative serum markers in ovarian carcinomaK Toftager-Larsen, U Hørding, A Dreisler, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Use of tetranectin, CA-125 and CASA to predict residual tumor and survival at second- and third-look operations for ovarian cancerC K Høgdall, E V Høgdall, U Hørding, et al.
British Journal of Obstetrics and Gynaecology|February 1, 1984
Fetal cephalometry by ultrasound as a screening procedure for the prenatal detection of Down's syndromeT B Perry, R J Benzie, N Cassar, et al.
European Journal of Gynaecological Oncology|January 1, 1994
The value of CA 125 measurement before second-look laparotomy in patients with ovarian carcinomaU Hørding, K Toftager-Larsen, B Lund, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 15, 1993
Immunoreactive inhibin-production in post-menopausal women with malignant epithelial ovarian tumorsJ Blaakaer, S Micic, I D Morris, et al.
Gynecologic and Obstetric Investigation|January 1, 1990
CA 125, placental alkaline phosphatase, and tissue polypeptide antigen in the monitoring of ovarian carcinoma. A comparative study of three different tumor markersU Hørding, K Toftager-Larsen, A Dreisler, et al.
Gynecologic and Obstetric Investigation|January 1, 1992
CA-125, placental alkaline phosphatase and tissue polypeptide antigen as preoperative serum markers in ovarian carcinomaK Toftager-Larsen, U Hørding, A Dreisler, et al.
Pageof 3